Page 9 - MRS Abstracts March 2023

Gout Study: Comorbidities and Uncontrolled Serum Uric Acid Predicts All-Cause Hospitalisation in Patients with Gout: Results from Monocentric Audit of Gout Patients
Introduction:
Dr Ajibade Adenitan, Senior Clinical Fellow Dr Naveen Ravichandran, Senior Clinical Fellow Dr Pallavi Vij, Senior Clinical Fellow
Dr Isaac Osobukola, FY2
Dr Latika Gupta, Consultant Rheumatologist Dr Hem Sapkota, Consultant Rheumatologist
New Cross Hospital
Gout is the most prevalent non-autoimmune mediated inflammatory arthritis commonly encountered and managed by rheumatologists and general practitioners (GPs). The continuous increase in prevalence and incidence of gout and the potentially debilitating nature of acute flare can lead to recurrent hospitalisation and prolonged hospital stays. Prompt diagnosis, optimisation of uric acid-lowering agents via treat-to-target gout clinics and understanding the preventable factors that preclude an increase in admission rate are essential for adequate management of gout patients.
This study looked at predictors of all causes of hospitalisations among patients with gout, emphasising serum uric acid and comorbidities. It highlighted the treat-to-target approach and continuous synergy between rheumatologists and other doctors involved in managing patients with gout.
Methods:
This hospital-based retrospective study was conducted by conveniently sampling the information of patients diagnosed with gout between August 2020 and October 2023 on the integrated electronic